GO:0006302 double-strand break repair: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0006302 double-strand break repair is the biological process that repairs DNA double-strand breaks via homologous and nonhomologous mechanisms to reform a continuous DNA helix.
Two major pathways dominate: non-homologous end joining (NHEJ), which directly ligates broken ends, and homologous recombination (HR), which uses a homologous template for high-fidelity repair.
Pathway choice is governed by DNA end resection, cell cycle phase, and chromatin context, with nucleosome remodeling influencing repair efficiency.
Defects in double-strand break repair are linked to cancer predisposition, male infertility, and sensitivity to DNA-damaging agents.
Transcription-coupled double-strand break repair preferentially repairs breaks in actively transcribed genes, highlighting crosstalk with RNA metabolism.
CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential for dissecting repair gene function and developing therapeutics.

Description

Double-strand breaks (DSBs) are among the most cytotoxic DNA lesions, and their repair is essential for genome stability. The Gene Ontology term GO:0006302, double-strand break repair, describes the cellular processes that detect and repair DSBs to restore a continuous DNA helix. This process encompasses multiple mechanistically distinct pathways, including non-homologous end joining (NHEJ) and homologous recombination (HR), each with unique protein requirements and cell cycle dependencies. Understanding DSB repair is fundamental to cancer biology, aging research, and the development of gene editing technologies. Defective DSB repair underlies numerous human pathologies, from hereditary breast and ovarian cancer to male infertility. Moreover, DSB repair pathways are directly relevant to CRISPR-Cas9 genome editing, as the outcomes of editing depend on the cell's repair machinery. Researchers studying this process require robust experimental models and tools to dissect pathway choice, identify novel factors, and evaluate therapeutic interventions.

double-strand break repair At A Glance

GO ID GO:0006302
GO term double-strand break repair
Ontology biological_process
Synonym none
Major function Repair of DNA double-strand breaks to restore a continuous DNA helix
Key pathways Non-homologous end joining (NHEJ), homologous recombination (HR), alternative end joining
Cellular context Nucleus, chromatin, cell cycle dependent
Disease relevance Cancer, infertility, neurodegeneration, immunodeficiency

What Is GO:0006302?

GO:0006302 double-strand break repair is defined as the repair of double-strand breaks in DNA via homologous and nonhomologous mechanisms to reform a continuous DNA helix. This biological process includes all molecular events that recognize, process, and ligate broken DNA ends, ensuring genome integrity.

Why Is double-strand break repair Important in Cell Biology?

Double-strand break repair is critical for maintaining genomic integrity and preventing mutations, chromosomal rearrangements, and cell death. Defects in this process lead to hypersensitivity to DNA-damaging agents, genomic instability, and a wide range of human diseases, including cancer and infertility. Furthermore, DSB repair mechanisms determine the outcomes of CRISPR-Cas9 gene editing, making them central to both basic research and therapeutic development.
Prevents genomic instability and mutations that drive cancer.
Essential for proper development and tissue homeostasis.
Determines sensitivity to radiotherapy and chemotherapy.
Underlies male infertility associated with defective spermatogenesis.
Influences CRISPR-Cas9 editing outcomes and precision.
Crosstalk with transcription and chromatin remodeling.
Target for cancer therapeutics (e.g., PARP inhibitors).
Required for immune diversity (V(D)J recombination).
Implicated in neurodegenerative diseases and aging.
Regulated by ubiquitination and deubiquitination.

What Happens During double-strand break repair?

DSB recognition and signaling
In simple terms: The cell detects a broken DNA end and sounds an alarm.
Upon DSB formation, sensor proteins such as the MRN complex (MRE11-RAD50-NBS1) and Ku70/Ku80 heterodimer rapidly bind DNA ends. This initiates signaling cascades, including ATM activation, which recruits repair factors and halts cell cycle progression. The choice between NHEJ and HR is influenced by the extent of end resection and cell cycle phase.
Non-homologous end joining (NHEJ)
In simple terms: The broken ends are simply glued back together, sometimes with small errors.
NHEJ is the predominant DSB repair pathway in mammalian cells, active throughout the cell cycle. It involves recognition of broken ends by Ku70/Ku80, recruitment of DNA-PKcs, processing of incompatible ends by Artemis, and ligation by DNA ligase IV/XRCC4/XLF. NHEJ is error-prone and can lead to small insertions or deletions, making it critical for V(D)J recombination but also mutagenic.
Homologous recombination (HR)
In simple terms: The cell uses a matching DNA template to accurately fix the break.
HR is a high-fidelity repair pathway active in S/G2 phases when a sister chromatid is available. It begins with DNA end resection by MRE11-CtIP-BLM to generate 3' single-stranded DNA overhangs. RAD51 mediates strand invasion into the homologous template, followed by DNA synthesis and resolution of Holliday junctions. HR is essential for repairing replication-associated DSBs and maintaining genome stability.
Alternative end joining (alt-EJ)
In simple terms: A backup gluing method that uses small stretches of matching sequence.
Alternative end joining (alt-EJ), also known as microhomology-mediated end joining (MMEJ), is a Ku-independent backup pathway that utilizes short microhomologies (5-25 bp) to align broken ends. It requires PARP1, DNA polymerase theta (POLQ), and MRE11, and is error-prone, often causing deletions. Alt-EJ is upregulated in NHEJ-deficient cells and contributes to genomic rearrangements in cancer.
Transcription-coupled DSB repair
In simple terms: Breaks in actively read genes get special attention.
DSBs occurring within actively transcribed genes are repaired preferentially by HR, a process termed transcription-coupled DSB repair. This involves RNA polymerase II stalling, recruitment of CSB and RAD52, and coordination with splicing factors. This pathway highlights the interplay between transcription and genome maintenance.
Chromatin remodeling and nucleosome dynamics
In simple terms: The cell loosens or tightens DNA packaging to allow repair.
Chromatin structure poses a barrier to DSB repair. Nucleosome remodeling complexes such as SWI/SNF, INO80, and RSC are recruited to DSBs to slide or evict nucleosomes, facilitating access for repair factors. Histone modifications (e.g., γH2AX, ubiquitination) also regulate repair factor recruitment and pathway choice.

Key Genes Involved in GO:0006302 double-strand break repair

The following genes encode core components and regulators of double-strand break repair, representing key targets for experimental interrogation.
GeneMajor RoleResearch Relevance
ATMDSB sensor kinase, activates checkpointMutated in ataxia-telangiectasia; radiosensitivity
MRE11End resection, MRN complexDefects in MRN cause ATLD; HR deficiency
RAD50MRN complex, tethering endsMutations linked to Nijmegen breakage syndrome-like
NBNMRN complex, DSB recognitionMutated in Nijmegen breakage syndrome
RAD51Strand invasion in HROverexpressed in cancers; target for therapy
BRCA1HR pathway choice, resectionMutated in hereditary breast/ovarian cancer
BRCA2RAD51 loadingFanconi anemia, breast cancer susceptibility
TP53BP1NHEJ promotion, blocks resectionLoss shifts repair to HR; cancer mutations
XRCC4NHEJ ligation complexDefects cause growth retardation, immunodeficiency
LIG4DNA ligase IV, NHEJ ligationMutations cause LIG4 syndrome
PRKDCDNA-PKcs, NHEJ kinaseDefects cause SCID in mice; radiosensitivity
POLQAlt-EJ polymeraseOverexpressed in HR-deficient cancers
PARP1Alt-EJ, SSB repairTarget of PARP inhibitors in BRCA-mutant cancers
CSB (ERCC6)Transcription-coupled DSB repairMutated in Cockayne syndrome
RAD52ssDNA annealing, HR backupSynthetic lethal with BRCA deficiency
BLMResection, Holliday junction resolutionMutated in Bloom syndrome
EXO1Long-range resectionModulates HR vs NHEJ choice
H2AXHistone variant, γH2AX formationMarker of DSBs; chromatin signaling

How Is double-strand break repair Regulated?

Double-strand break repair is tightly regulated at multiple levels. Cell cycle phase controls pathway choice: NHEJ is active throughout the cycle, while HR is restricted to S/G2 when a sister chromatid is available. Post-translational modifications, particularly ubiquitination and deubiquitination, regulate the stability and activity of repair factors such as BRCA1, 53BP1, and RAD51. Deubiquitinating enzymes (DUBs) remove ubiquitin chains from repair proteins, influencing their recruitment and function. Chromatin remodeling complexes and histone modifications also modulate repair efficiency and pathway selection. Additionally, transcription-coupled DSB repair is regulated by RNA polymerase II elongation and splicing factors.

double-strand break repair and Human Disease

GeneDisease / BiologyPotential Experimental Model
BRCA1Hereditary breast/ovarian cancerKnockout in MCF10A; point mutation in RING domain
ATMAtaxia-telangiectasiaKnockout in HEK293; kinase-dead point mutation
LIG4LIG4 syndrome, immunodeficiencyKnock-in of patient mutations in HCT116
RAD51Male infertility, cancerOverexpression in cancer cell lines; KO in spermatogonia
POLQHR-deficient cancersKnockout in BRCA-mutant cells; overexpression in HR-proficient
Cancer predisposition and genomic instability
Defects in DSB repair genes are strongly associated with cancer predisposition. Mutations in BRCA1 and BRCA2 impair HR, leading to hereditary breast and ovarian cancer. Loss of ATM or TP53BP1 disrupts DNA damage signaling and repair, increasing genomic instability. Tumors with HR deficiency are sensitive to PARP inhibitors, which induce synthetic lethality by blocking alternative repair pathways.
Male infertility
DSB repair is essential for spermatogenesis, particularly during meiotic recombination. Defects in HR genes such as RAD51 and DMC1 are linked to male infertility and azoospermia. Impaired DSB repair in germ cells can lead to meiotic arrest and germ cell apoptosis.
Neurodegeneration and aging
Neurons are post-mitotic and rely heavily on NHEJ for DSB repair. Defects in NHEJ factors such as LIG4 and XRCC4 cause neurodevelopmental disorders and neurodegeneration. Accumulation of unrepaired DSBs contributes to aging and age-related diseases.
Immunodeficiency
NHEJ is required for V(D)J recombination, which generates antibody and T-cell receptor diversity. Mutations in NHEJ genes (e.g., PRKDC, LIG4, XRCC4) cause severe combined immunodeficiency (SCID) and radiosensitivity.

From double-strand break repair-Related Genes to Experimental Models

Research QuestionSuitable Model
Does gene X promote NHEJ or HR?Knockout cell line (e.g., HEK293, U2OS) with reporter assays
Does a patient mutation impair repair?Point mutation knock-in via CRISPR in isogenic cell line
Can a repair factor be visualized at DSBs?Tagged knock-in (e.g., GFP-RAD51) and live-cell imaging
Does overexpression of gene X cause chemoresistance?Overexpression cell line treated with DNA-damaging agents
What is the role of gene X in spermatogenesis?Knockout mouse model or spermatogonial stem cell KO
Can we identify synthetic lethal partners?CRISPR library screening in repair-deficient background

How to Study the double-strand break repair Process

MethodWhat It MeasuresTypical Application
DR-GFP reporterHR efficiencyAssess BRCA1/2 function
EJ5-GFP reporterNHEJ efficiencyEvaluate Ku70/80 or LIG4 activity
γH2AX immunofluorescenceDSB formation and repair kineticsDrug sensitivity testing
RAD51 fociHR activationPredict PARP inhibitor response
ChIP-seqRepair factor binding sitesMap γH2AX or 53BP1 across genome
CRISPR library screenGene essentiality in repairIdentify synthetic lethal targets
Mass spectrometryProtein interactionsDiscover novel repair complexes
Reporter-based DSB repair assays
Fluorescent or luminescent reporters (e.g., DR-GFP for HR, EJ5-GFP for NHEJ) are widely used to measure repair pathway activity in cells. These assays involve site-specific DSB induction by I-SceI or CRISPR-Cas9 and quantification of repair events.
Imaging and foci analysis
Immunofluorescence for γH2AX, 53BP1, or RAD51 foci allows visualization and quantification of DSB repair at the single-cell level. Live-cell imaging with tagged repair proteins provides real-time dynamics.
Genomic and proteomic approaches
Next-generation sequencing (e.g., whole-genome sequencing, ChIP-seq) and mass spectrometry-based proteomics identify repair factor recruitment and genomic rearrangements. CRISPR screens enable unbiased discovery of novel repair genes.
Biochemical reconstitution
In vitro assays with purified proteins (e.g., DNA ligation, strand exchange) reconstitute specific repair steps and define molecular mechanisms.

How CRISPR Can Be Used to Study GO:0006302 double-strand break repair

Knockout

CRISPR knockout of DSB repair genes (e.g., BRCA1, ATM, LIG4) creates isogenic models to study pathway dependencies and drug sensitivity. Knockout cell lines are essential for synthetic lethality screens and functional validation.

Point Mutation

Point mutations identified in patient tumors or congenital syndromes (e.g., ATM kinase-dead, BRCA1 missense) can be introduced via CRISPR base editing or HDR to dissect specific domain functions.

Knock-in

Knock-in of tagged repair proteins (e.g., GFP-RAD51, HA-BRCA1) enables live-cell imaging and proteomic analysis of repair dynamics. Knock-in of patient mutations in endogenous loci preserves physiological regulation.

Overexpression

Overexpression of repair genes (e.g., RAD51, POLQ) via CRISPR activation or lentiviral delivery models chemoresistance and identifies drivers of genomic instability.

How EDITGENE Supports double-strand break repair Research

Researchers studying double-strand break repair-related genes often need to determine whether a candidate gene is causally involved in repair pathway choice, genomic stability, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and drug discovery.
Contact EDITGENE today to design your custom CRISPR model for double-strand break repair research.

Frequently Asked Questions About double-strand break repair

Double-strand break repair is the biological process that repairs DNA double-strand breaks via homologous and nonhomologous mechanisms to reform a continuous DNA helix.
Key genes include ATM, BRCA1, BRCA2, RAD51, MRE11, RAD50, NBN, TP53BP1, XRCC4, LIG4, PRKDC, POLQ, PARP1, and others.
The two main pathways are non-homologous end joining (NHEJ) and homologous recombination (HR).
Pathway choice is regulated by DNA end resection, cell cycle phase, and chromatin context, with 53BP1 promoting NHEJ and BRCA1 promoting HR.
Defects are linked to cancer (e.g., BRCA mutations), male infertility, neurodegeneration, and immunodeficiency.
Common methods include reporter assays (DR-GFP, EJ5-GFP), immunofluorescence for γH2AX or RAD51 foci, and CRISPR screens.
RAD51 mediates strand invasion during homologous recombination, a critical step for high-fidelity repair.
It is a specialized pathway that preferentially repairs DSBs in actively transcribed genes, involving RNA polymerase II and CSB.
Nucleosome remodeling complexes such as SWI/SNF and INO80 facilitate access of repair factors to DNA breaks.
Knockout, point mutation, knock-in, and overexpression models can be generated to dissect gene function and therapeutic potential.

Conclusion

GO:0006302 double-strand break repair is a fundamental biological process that safeguards genome integrity through coordinated pathways including NHEJ, HR, and alternative end joining. Its dysregulation underlies cancer, infertility, and other diseases, making it a prime target for therapeutic intervention. Advances in CRISPR-based modeling and screening technologies continue to accelerate the discovery of novel repair factors and drug targets. EDITGENE provides comprehensive services to support these efforts, from custom cell line generation to high-throughput screening and bioinformatics analysis.

References

  1. 1. Chang HHY et al.. 2017. Non-homologous DNA end joining and alternative pathways to double-strand break repair.. Nat Rev Mol Cell Biol 18(8):495-506 PMID: 28512351
  2. 2. Symington LS et al.. 2011. Double-strand break end resection and repair pathway choice.. Annu Rev Genet 45:247-71 PMID: 21910633
  3. 3. Lieber MR. 2010. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.. Annu Rev Biochem 79:181-211 PMID: 20192759
  4. 4. Guha S et al.. 2022. Transcription-coupled DNA double-strand break repair.. DNA Repair (Amst) 109:103211 PMID: 34883263
  5. 5. Karl LA et al.. 2021. DNA Double Strand Break Repair and Its Control by Nucleosome Remodeling.. Front Genet 12:821543 PMID: 35096025
  6. 6. Vítor AC et al.. 2020. Studying DNA Double-Strand Break Repair: An Ever-Growing Toolbox.. Front Mol Biosci 7:24 PMID: 32154266
  7. 7. Talibova G et al.. 2022. DNA double-strand break repair in male germ cells during spermatogenesis and its association with male infertility development.. DNA Repair (Amst) 118:103386 PMID: 35963140
  8. 8. Li Y et al.. 2021. Role of deubiquitinating enzymes in DNA double-strand break repair.. J Zhejiang Univ Sci B 22(1):63-72 PMID: 33448188
Contact Us
*
*
*
*
How did you hear about us: